Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canada invests in spinal injury research in a five-year programme:

This article was originally published in Clinica

Executive Summary

Canada has pledged Can$30m (US$25m) over five years to a foundation dedicated to research and treatment of spinal injury. The funds will be used by the Rick Hansen foundation's Spinal Cord Industry Translational Research Network to -accelerate scientific advances towards a cure" and to build infrastructure "needed to keep Canada on the leading edge of spinal cord research". Other objectives of the foundation include establishing best practices in spinal cure treatment, acceleration of practical application of cures and completing the roll-out of a national registry of patients and their medical histories as a reporting and tracking tool.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT047551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel